BB Biotech AG earns after-tax profits of CHF 141 million as of September 30, 2015
(Thomson Reuters ONE) -
BB BIOTECH AG /
BB Biotech AG earns after-tax profits of CHF 141 million as of September 30,
2015
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN
CH0038389992) is releasing the following information about its profits of the
interim financial statements as of September 30, 2015.
Based on preliminary unaudited consolidated results, BB Biotech AG reports for
the nine months period ended September 30, 2015 a profit of CHF 141 million (CHF
744 million in the corresponding period of the previous year). In the third
quarter a loss of CHF 575 million (profit of CHF 483 million in the
corresponding period of the previous year) was incurred.
The interim report as of September 30, 2015 will be published on October
16, 2015.
For further information:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland
Tanja Chicherio, Tel. +41 44 267 67 07, tch(at)bellevue.ch
www.bbbiotech.com
Company profile
BB Biotech invests in companies in the fast growing market of biotechnology and
is one of the world's largest investors in this sector with approx. CHF 3.5
billion in assets under management. BB Biotech is listed in Switzerland, Germany
and Italy. Its investments are focused on listed companies that are developing
and commercializing novel medical treatments and cures. BB Biotech's investment
selection process is guided by the fundamental research and analysis of
physicians and molecular biologists. Its Board of Directors has many years of
experience in industry and science.
Press release:
http://hugin.info/130285/R/1957469/713161.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB BIOTECH AG via GlobeNewswire
[HUG#1957469]
Datum: 07.10.2015 - 18:10 Uhr
Sprache: Deutsch
News-ID 425492
Anzahl Zeichen: 2598
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 164 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BB Biotech AG earns after-tax profits of CHF 141 million as of September 30, 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
BB BIOTECH AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
